Trade Mark Journal No.2026/042 16 October 2026
WO0000001940508 (5,9,42)
Office of origin: United States of America
Date of International Registration:9 July 2026
Date of designation in the UK:
9 July 2026
Registration of this mark shall give no right to the exclusive use of "BIO"
International priority date claimed: 9 January 2026
(United States of America)
(99585836)
International priority date claimed: 9 January 2026
(United States of America)
(99585846)
International priority date claimed: 27 January 2026
(United States of America)
(99617226)
- Class 5
- Pharmaceutical preparations for the treatment of cancer; anti-cancer preparations.
- Class 9
- Downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data; next-generation sequencing (NGS) data processor; bioinformatics data processor.
- Class 42
- Conducting early evaluations in the field of new pharmaceuticals; pharmaceutical products development; pharmaceutical product evaluation; pharmaceutical research and development; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of new technology for others in the field of cancer immunotherapy platforms for manufacturing therapeutics; scientific and technological services, namely, scientific research of specific molecular and genomic data for analytical and clinical purposes in the field of treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Gritstone bio, Inc.
Representative: Shauna M. Wertheim The Marbury Law Group, PLLC, 11800 Sunrise Valley Drive, 15th Floor, Reston VA 20191, UNITED STATES OF AMERICA